RACGP criticises push to make asthma preventer OTC
The TGA will consider the unnamed application for inhaled budesonide later this month.
The TGA will consider the unnamed application for inhaled budesonide later this month.
New asthma management guidance includes a role for second-line use of e-cigarettes as a quit aid.
First large study into asthma outcomes upends earlier studies by showing infected children require more medical treatments.
A large cohort study finds several patient and disease-related factors predict a greater risk for weight gain.Â
The implications of the condition need to be better understood, the researcher says.
An international body recommends simultaneous preventer and reliever use even with mild intermittent symptoms.
A best practice approach to achieving symptom control
This case study highlights the problem and suggests a strategy to combat it
A useful lesson on how to assess lung function
Handy infographic for navigating the changing treatment landscapeÂ
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.